Diabetic foot ulcer's impaired wound healing, which leads to the development of chronic non-healing wounds and ultimately amputation, is a major problem worldwide. Although recently endothelial progenitor cell-derived cell therapy has been used as a therapeutic intervention to treat diabetic wounds, thereby promoting neovascularization, the results, however, are not satisfactory. In this article, we have discussed the several steps that are involved in the neovascularization process, which might be impaired during diabetes. In addition, we have also discussed the reported possible interventions to correct these impairments. Thus, we have summarized neovascularization as a process with a coordinated sequence of multiple steps and thus, there is the need of a combined therapeutic approach to achieve better treatment outcomes.
Get full access to this article
View all access options for this article.
References
1.
AckermannM., PabstA.M., HoudekJ.P., ZiebartT., and KonerdingM.A. (2014). Priming with proangiogenic growth factors and endothelial progenitor cells improves revascularization in linear diabetic wounds. Int. J. Mol. Med., 33, 833–839.
2.
AckermannM., WolloscheckT., WellmannA., LiV.W., LiW.W., and KonerdingM.A. (2011). Priming with a combination of proangiogenic growth factors Enhances wound healing in streptozotocin-induced diabetes in mice. Eur. Surg. Res., 47, 81–89.
3.
AicherA., HeeschenC., Mildner-RihmC., UrbichC., IhlingC., Technau-IhlingK., ZeiherA.M., and DimmelerS. (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med., 9, 1370–1376.
4.
AlbieroM., PoncinaN., TjwaM., CiciliotS., MenegazzoL., CeolottoG., Vigili de KreutzenbergS., MouraR., GiorgioM., PelicciP., AvogaroA., and FadiniG.P. (2014). Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes, 63, 1353–1365.
5.
BadorffC., BrandesR.P., PoppR., RuppS., UrbichC., AicherA., FlemingI., BusseR., ZeiherA.M., and DimmelerS. (2003). Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation, 107, 1024–1032.
6.
BalajiS., KingA., CrombleholmeT.M., and KeswaniS.G. (2013). The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv. Wound Care (New Rochelle), 2, 283–295.
7.
BalestrieriM.L., RienzoM., FeliceF., RossielloR., GrimaldiV., MiloneL., CasamassimiA., ServilloL., FarzatiB., GiovaneA., and NapoliC. (2008). High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim. Biophys. Acta, 1784, 936–945.
8.
BarcelosL.S., DuplaaC., KränkelN., GraianiG., InverniciG., KatareR., SiragusaM., MeloniM., CampesiI., MonicaM., SimmA., CampagnoloP., MangialardiG., StevanatoL., AlessandriG., EmanueliC., and MadedduP. (2009). Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res., 104, 1095–1102.
9.
BascianoL., NemosC., FoliguetB., de IslaN., de CarvalhoM., TranN., and DalloulA. (2011). Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol., 12, 12.
10.
BellotG., Garcia-MedinaR., GounonP., ChicheJ., RouxD., PouysségurJ., and MazureN.M. (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol., 29, 2570–2581.
11.
BentoC.F., FernandesR., RamalhoJ., MarquesC., ShangF., TaylorA., and PereiraP. (2010). The chaperone-dependent ubiquitin ligase CHIP targets HIF-1alpha for degradation in the presence of methylglyoxal. PLoS One, 5, e15062
12.
BotusanI.R., SunkariV.G., SavuO., CatrinaA.I., GrünlerJ., LindbergS., PereiraT., Ylä-HerttualaS., PoellingerL., BrismarK., and CatrinaS.B. (2008). Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc. Natl Acad. Sci. U. S. A., 105, 19426–19431.
13.
BremH., and Tomic-CanicM. (2007). Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest., 117, 1219–1222.
14.
CamiciG.G., Schiavoni.M., FranciaP., BachschmidM., Martin-PaduraI., HersbergerM., TannerF.C., PelicciP., VolpeM., AnversaP., LüscherT.F., and CosentinoF. (2007). Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc. Natl Acad. Sci. U. S. A., 104, 5217–5222.
15.
CaseJ., MeadL.E., BesslerW.K., PraterD., WhiteH.A., SaadatzadehM.R., BhavsarJ.R., YoderM.C., HanelineL.S., and IngramD.A. (2007). Human cd34+ac133+vegfr-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol., 35, 1109–1118.
16.
CatrinaS.B., and ZhengX. (2016). Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers. Diabetes Metab. Res. Rev., 1, 179–185.
17.
ChavakisE., HainA., VinciM., CarmonaG., BianchiM.E., VajkoczyP., ZeiherA.M., ChavakisT., and DimmelerS. (2007). High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ. Res., 100, 204–212.
18.
ChenD.D., and ChenA.F. (2006). CuZn superoxide dismutasedeficiency: culprit of accelerated vascular aging process. Hypertension, 48, 1026–1028.
19.
ChenW., WuY., LiL., YangM., ShenL., LiuG., TanJ., ZengW., and ZhuC. (2015a). Adenosine accelerates the healing of diabetic ischemic ulcers by improving autophagy of endothelial progenitor cells grown on a biomaterial. Sci. Rep., 5, 11594.
20.
ChenX., GongJ., ZengH., ChenN., HuangR., HuangY., NieL., XuM., XiaJ., ZhaoF., MengW., and ZhouQ. (2010). MicroRNA145 targets BNIP3 and supresses prostate cancer progression. Cancer Res. 70, 2728–2738.
21.
ChenY., and GorskiD.H. (2008). Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates anti-angiogenic homebox gene GAX and HOXA5. Blood, 111, 1217–1226.
22.
ChenY., QiaoF., ZhaoY., WangY., and LiuG. (2015b). HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose. Int. J. Clin. Exp. Pathol., 8, 6683–6691.
23.
ChiangK.H., ChengW.L., ShihC.M., LinY.W., TsaoN.W., KaoY.T., LinC.T., WuS.C., HuangC.Y., and LinF.Y. (2015). Statins, HMG-CoA reductase inhibitors, improve neovascularization by increasing the expression density of CXCR4 in endothelial progenitor cells. PLoS One., 10, e0136405.
24.
de KreutzenbergS.V., CeolottoG., PapparellaI., BortoluzziA., SempliciniA., Dalla ManC., CobelliC., FadiniG.P., and AvogaroA. (2010). Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolicsyndrome: potential biochemical mechanisms. Diabetes, 59, 1006–1015.
25.
DernbachE., UrbichC., BrandesR.P., et al. (2004). Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood, 104, 3591–3597.
26.
Di StefanoV., CencioniC., ZaccagniniG., MagentaA., CapogrossiM.C., and MartelliF. (2009). p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc. Res., 82, 421–429.
27.
ElsharawyM.A., NaimM., and GreishS. (2012). Human CD34+ stem cells promote healing of diabetic foot ulcer in rats. Interact. Cardiovasc. Thorac. Surg., 14, 288–293.
28.
FadiniG.P., BoscaroE., AlbieroM., MenegazzoL., FrisonV., de KreutzenbergS., AgostiniC., TiengoA., and AvogaroA. (2010). The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care, 33, 1607–1609.
29.
FadiniG.P., LosordoD., and DimmelerS. (2012). Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ. Res., 110, 624–637.
30.
FalangaV. (2005). Wound healing and its impairment in the diabetic foot. Lancet, 366, 1736–1743.
31.
GalkowskaH., WojewodzkaU., andOlszewski. (2006). Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 14, 558–565.
32.
GallagherK.A., LiuZ.J., XiaoM., ChenH., GoldsteinL.J., BuerkD.G., NedeauA., ThomS.R., and VelazquezO.C. (2007). Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest., 117, 1249–1259.
33.
GiorgioM., MigliaccioE., OrsiniF., PaolucciD., MoroniM., ContursiC., PellicciaG., LuziL., MinucciS., MarcaccioM., PintonP., RizzutoR., BernardiP., PaolucciF., and PelicciP.G. (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122, 221–233.
34.
GuY., ZhangJ., and QiL. (2007). Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 21, 675–678.
35.
HagensenM.K., RaarupM.K., MortensenM.B., ThimT., NyengaardJ.R., FalkE., and BentzonJ.F. (2012). Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res, 93, 223–331.
36.
HannaR.A., QuinsayM.N., OrogoA.M., GiangK., RikkaS., andGustafssonÅ.B. (2012). Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem., 287, 19094–19104.
37.
HayakawaK., MiyamotoN., SeoJ.H., PhamL.D., KimK.W., LoE.H., and AraiK. (2013). High mobility group box 1 from reactive astrocyte enhances the accumulation of endothelial progenitor cells in damaged white matter. J. Neurochem., 125, 273–280.
38.
HayakawaK., PhamL.D., AraiK., and LoE.H. (2014). Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB 1 and beta-2 integrin signaling. Stem Cell Res. 12, 531–538.
39.
HeT., PetersonT.E., HolmuhamedovE.L., TerzicA., CapliceN.M., OberleyL.W., and KatusicZ.S. (2004). Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler. Thromb. Vasc. Biol., 24, 2021–2027.
40.
HeissigB., HattoriK., DiasS., FriedrichM., FerrisB., HackettN.R., CrystalR.G., BesmerP., LydenD., MooreM.A., WerbZ., and RafiiS. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109, 625–637.
41.
HeissigB., WerbZ., RafiiS., and HattoriK. (2003). Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb. Haemost., 90, 570–576.
42.
HermekingH. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193–199.
43.
HoriO., BrettJ., SlatteryT., CaoR., ZhangJ., ChenJ.X., NagashimaM., LundhE.R., VijayS., NiteckiD., MorserJ., DavidS., and SchmidtA.M. (1995). The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem., 270, 25752–25761.
44.
HristovM., ErlW., and WeberP.C. (2003). Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler. Thromb. Vasc. Biol., 23, 1185–1189.
45.
HuN., KongL.S., ChenH., LiW.D., QianA.M., WangX.Y., DuX.L., LiC.L., YuX.B., and LiX.Q. (2015). Autophagy protein 5 enhances the function of rat EPCs and promotes EPCs homing and thrombus recanalization via activating AKT. Thromb. Res., 136, 642–651.
46.
HurJ., YoonC.H., KimH.S., ChoiJ.H., KangH.J., HwangK.K., OhB.H., LeeM.M., and ParkY.B. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol., 24, 288–293.
47.
JarajapuY.P., and GrantM.B. (2010). The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ. Res., 106, 854–869.
48.
JohansenT., and LamarkT. (2011). Selective autophagy mediated by autophagic adapter proteins. Autophagy, 7, 279–296.
49.
KangC., YouY.J., and AveryL. (2007). Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation. Genes Dev. 21, 2161–2171.
50.
KangR., TangD., SchapiroN.E., LouxT., LiveseyK.M., BilliarT.R., WangH., Van HoutenB., LotzeM.T., and ZehH.J. (2014). The HMGB1/RAGE inflammatory pathway promotes pancre- atic tumor growth by regulating mitochondrial bioenergetics. Oncogene. 33, 567–577.
51.
KanzlerI., TuchscheererN., SteffensG., SimsekyilmazS., KonschallaS., KrohA., SimonsD., AsareY., SchoberA., BucalaR., WeberC., BernhagenJ., and LiehnE.A. (2013). Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res. Cardiol., 108, 310.
52.
KhandayF.A., YamamoriT., MattagajasinghI., ZhangZ., BugayenkoA., NaqviA., SanthanamL., NabiN., KasunoK., DayB.W., and IraniK. (2006). Rac1 leads to phosphorylation-dependent increase in stability of the p66Shc adaptor protein: role in Rac1-induced oxidative stress. Mol. Biol. Cell, 17, 122–129.
53.
KimK.A., ShinY.J., AkramM., KimE.S., ChoiK.W., SuhH., LeeC.H., and BaeO.N. (2014). High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. Biol. Pharm. Bull., 37, 1248–1252.
54.
KiranaS., StratmannB., LammersD., NegreanM., StirbanA., MinartzP., KoerperichH., GastensM.H., GöttingC., ProhaskaW, KleesiekK., and TschoepeD. (2007). Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int. J. Clin. Pract., 61, 690–7022.
55.
KlemannC., WagnerL., StephanM., and von HörstenS. (2016). Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. Clin. Exp. Immunol., 185, 1–21.
56.
KränkelN., AdamsV., LinkeA., GielenS., ErbsS., LenkK., SchulerG., and HambrechtR. (2005). Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol., 25, 698–703.
57.
KuetheF., RichartzB.M., KasperC., SayerH.G., HoeffkenK., WernerG.S., and FigullaH.R. (2005). Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int. J. Cardiol., 100, 485–491.
58.
KuetheF., RichartzB.M., SayerH.G., KasperC., WernerG.S., HöffkenK., and FigullaH.R. (2004). Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int. J. Cardiol., 97, 123–127.
59.
KulwasA., DrelaE., JundziłłW., GóralczykB., Ruszkowska-CiastekB., and RośćD. (2015). Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications. J. Diabetes Complications, 29, 686–690.
60.
KureishiY., LuoZ., ShiojimaI., BialikA., FultonD., LeferD.J., SessaW.C., and WalshK. (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 6, 1004–1010.
61.
LevineB., and KroemerG. (2008). Autophagy in the pathogenesis of disease. Cell, 132, 27–42.
62.
LiB., OgasawaraA.K., YangR., WeiW., HeG.W., ZioncheckT.F., BuntingS., de VosA.M., and JinH. (2002). KDR (VEGF receptor2) is the major mediator for the hypotensive effect of VEGF. Hypertension, 39, 1095–1100.
63.
LindemannA., and RumbergerB. (1993). Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur J Cancer., 29A, 2338–2339.
64.
LiuZ.J., and VelazquezO.C. (2008). Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal. 10, 1869–1882.
65.
MaceK.A., YuD.H., PaydarK.Z., BoudreauN., and YoungD.M. (2007). Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair. Wound Repair Regen. 15, 636–645.
66.
MaiuriM.C., Le ToumelinG., CriolloA., RainJ.C., GautierF., JuinP., TasdemirE., PierronG., TroulinakiK., TavernarakisN., HickmanJ.A., GenesteO., and KroemerG. (2007). Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26, 2527–2539.
67.
MannucciE., PalaL., CianiS., BardiniG., PezzatiniA., SposatoI., CremascoF., OgnibeneA., and RotellaC.M. (2005). Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia, 48, 1168–1172.
68.
MarrotteE.J., ChenD.D., HakimJ.S., BoudreauN., and YoungD.M. (2010). Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing indiabetic mice. J. Clin. Invest., 120, 4207–4219.
69.
MasiniM., BuglianiM., LupiR., del GuerraS., BoggiU., FilipponiF., MarselliL., MasielloP., and MarchettiP. (2009). Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia, 52, 1083–1086.
70.
MasudaH., and AsaharaT. (2003). Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc. Res., 58, 390–398
71.
MeijerA.J., and CodognoP. (2008). Autophagy: a sweet process in diabetes. Cell Metab. 8, 275–276.
72.
MeneveauN., DeschaseauxF., SerondeM.F., ChopardR., SchieleF., JehlJ, TiberghienP., BassandJ.P., KantelipJ.P., and DavaniS. (2011). Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction. Basic Res. Cardiol., 106, 1397–1410.
73.
MengS., CaoJ., ZhangX., FanY., FangL., WangC., LvZ., FuD., and LiY. (2013). Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS One, 8, e68611.
74.
MouraJ., BørsheimE., and CarvalhoE. (2014). The role of MicroRNA in diabetic complications-special emphasis on wound healing. Genes (Basel), 5, 926–956.
75.
MudaliarH., PollockC., MaJ., WuH., ChadbanS., and PanchapakesanU. (2014). The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PLoS One, 9, e108844.
76.
NaganoM., YamashitaT., HamadaH., OhnedaK., KimuraK., NakagawaT., ShibuyaM., YoshikawaH., and OhnedaO. (2007). Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood, 110, 151–160.
77.
NakamuraY., TajimaF., IshigaK., YamazakiH., OshimuraM., ShiotaG., and MurawakiY. (2004). Soluble c-kit receptor mobilizes hematopoietic stem cells to peripheral blood in mice. Exp. Hematol., 32, 390–396.
78.
NemotoS., and FinkelT. (2002). Redox regulation of forkhead proteins through a p66Shc-dependent signaling pathway. Science, 295, 2450–2452.
79.
ParkJ.S., SvetkauskaiteD., HeQ., KimJ.Y., StrassheimD., IshizakaA., and AbrahamE. (2004). Involvement of toll-like receptors-2 and 4 in cellular activation by high mobility group box1 protein. J Biol Chem. 279, 7370–7377.
80.
PatenaudeA., ParkerJ., and KarsanA. (2010). Involvement of endothelial progenitor cells in tumor vascularization. Microvasc. Res., 79, 217–223.
81.
PedersonR.A., WhiteH.A., SchlenzigD., PaulyR.P., McIntoshC.H., and DemuthH.U. (1998). Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes, 47, 1253–1258.
82.
PintonP., RimessiA., MarchiS., OrsiniF., MigliaccioE., GiorgioM., ContursiC., MinucciS., MantovaniF., WieckowskiM.R., Del SalG., PelicciP.G., and RizzutoR. (2007). Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 315, 659–663.
83.
PolisenoL., TuccoliA., MarianiL., EvangelistaM., CittiL., WoodsK., MercatantiA., HammondS., and RainaldiG. (2006). MicroRNAs modulate the angiogenic properties of HUVECs. Blood, 108, 3068–3071.
84.
Prado-LopezS., ConesaA., ArminanA., Martínez-LosaM., Escobedo-LuceaC., GandiaC., TarazonaS., MelguizoD., BlesaD., MontanerD., Sanz-GonzálezS., SepúlvedaP., GötzS., O'ConnorJ.E., MorenoR., DopazoJ., BurksD.J., and StojkovicM. (2010). Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells, 28, 407–418.
85.
QinG., IiM., SilverM., WeckerA., BordE., MaH., GavinM., GoukassianD.A., YoonY.S., PapayannopoulouT., AsaharaT., KearneyM., ThorneT., CurryC., EatonL., HeydL., DineshD., KishoreR., ZhuY., and LosordoD.W. (2006). Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J. Exp. Med., 203, 153–163.
86.
RafiiS., AvecillaS., ShmelkovS., ShidoK., TejadaR., MooreM.A., HeissigB., and HattoriK. (2003). Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann N Y Acad Sci. 996, 49–60.
87.
RafiiS., MeeusS., DiasS., HattoriK., HeissigB., ShmelkovS., RafiiD., and LydenD. (2002). Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin. Cell Dev. Biol., 13, 61–67.
88.
RamseyS.D., NewtonK., BloughD., McCullochD.K., SandhuN., ReiberG.E., and WagnerE.H. (1999). Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 22, 382–387.
89.
RöhrbornD., WronkowitzN., and EckelJ. (2015). DPP4 in diabetes. Front Immunol., 6, 386.
90.
RyzhovS., SolenkovaN.V., GoldsteinA.E., LamparterM., FleenorT., YoungP.P., GreelishJ.P., ByrneJ.G., VaughanD.E., BiaggioniI., HatzopoulosA.K., and FeoktistovI. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ. Res., 102, 356–363.
91.
SchattemanG.C., DunnwaldM., and JiaoC. (2007). Biology of bone marrow derived endothelial cell precursors. Am. J. Physiol. Heart Circ. Physiol., 292, 1–18.
92.
ScheenA.J. (2012). DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials. Diabetes Metab. 38, 89–101.
93.
ShintaniS., MuroharaT., IkedaH., UenoT., HonmaT., KatohA., SasakiK., ShimadaT., OikeY., and ImaizumiT. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103, 2776–2779.
94.
SievekingD.P., BuckleA., CelermajerD.S., and NgM.K. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol., 51, 660–668.
95.
SmiellJ.M., WiemanT.J., SteedD.L., PerryB.H., SampsonA.R., and SchwabB.H. (1999). Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 7, 335–346.
96.
SuarezY., and SessaW.C. (2009). MicroRNAs as novel regulators of angiogenesis. Circ. Res., 104, 442–454.
97.
SukmawatiD., and TanakaR. (2015). Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am. J. Transl. Res., 7, 411–421.
98.
TangD., KangR., ChehC.W., LiveseyK.M., LiangX., SchapiroN.E., BenschopR., SparveroL.J., AmoscatoA.A., TraceyK.J., ZehH.J., and LotzeM.T. (2010a). HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene, 29, 5299–5310.
TangD., KangR., LiveseyK.M., KroemerG., BilliarT.R., Van HoutenB., ZehH.J.3rd, and LotzeMT. (2011). High-mobility group box1 is essential for mitochondrial quality control. Cell Metab. 13, 701–711.
101.
TecilazichF., DinhT., Pradhan-NabzdykL., LealE., TellecheaA., KafanasA., GnardellisC., MagargeeM.L., DejamA., ToxavidisV., TiggesJ.C., CarvalhoE., LyonsT.E., and VevesA. (2013). Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One, 8, e83314.
102.
ThangarajahH., YaoD., ChangE.I., ShiY., JazayeriL., VialI.N., GalianoR.D., DuX.L., GroganR., GalvezM.G., JanuszykM., BrownleeM., and GurtnerG.C. (2009). The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc. Natl Acad. Sci. U. S. A., 106, 13505–13510.
103.
TianF., LiangP.H., and LiL.Y. (2009). Inhibition of endothelial progenitor cell differentiation by VEGI. Blood, 113, 5352–5360.
104.
TsaoC.F., HuangW.T., LiuT.T., WangP.W., LiouC.W., LinT.K., HsiehC.J., and WengS.W. (2015). Expression of high-mobility group box protein 1 in diabetic foot atherogenesis. Genet. Mol. Res., 14, 4521–4531.
105.
UrbichC., DernbachE., ZeiherA.M., and DimmelerS. (2002). Double-edged role of statins in angiogenesis signaling. Circ. Res., 90, 737–744.
106.
UrbichC., KuehbacherA., and DimmelerS. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res., 79, 581–588.
107.
VenereauE., CasalgrandiM., SchiraldiM., AntoineD.J., CattaneoA., De MarchisF., LiuJ., AntonelliA., PretiA., RaeliL., ShamsS.S., YangH., VaraniL., AnderssonU., TraceyK.J., BachiA., UguccioniM., and BianchiM.E. (2012). Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med., 209, 1519–1528.
108.
WangC.H., HsiehI.C., Su PangJ.H., CherngW.J., LinS.J., TungT.H., and MeiH.F. (2011). Factors associated with purity, biological function, and activation potential of endothelial colony-forming cells. Am. J. Physiol. Regul. Integr. Comp. Physiol., 300, 586–594.
109.
WangH.J., ZhangD., TanY.Z., and LiT. (2013). Autophagy in endothelial progenitor cell is cytoprotective in hypoxic conditions. Am. J. Physiol. Cell. Physiol., 304, C617–C726.
110.
WerlingN.J., ThorpeR., and ZhaoY. (2013). A systematic approach to the establishment and characterization of endothelial progenitor cells for gene therapy. Hum. Gene Ther. Methods., 24, 171–184.
111.
WickersheimA., KerberM., de MiguelL.S., PlateK.H., and MacheinM.R. (2009). Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int. J. Cancer, 125, 1771–1777.
112.
WilsJ., FavreJ., and BellienJ. (2016). Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction andcardiovascular complications in diabetes. Pharmacol. Ther. pii: S0163-7258, 30193–30200.
113.
XuQ., MengS., LiuB., LiM.Q., LiY., FangL., and LiY.G. (2014). MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3. Clin. Exp. Pharmacol. Physiol., 41, 351–357.
114.
YangX.F., WuY.X., WangH.M., XuY.F., LüX., ZhangY.B., WangF., and ZhangY. (2005). Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder. Zhonghua Nei Ke Za Zhi, 44, 95–98.
ZarubaM.M., TheissH.D., VallasterM., MehlU., BrunnerS., DavidR., FischerR., KriegL., HirschE., HuberB., NathanP., IsraelL., ImhofA., HerbachN., AssmannG., WankeR., Mueller-HoeckerJ., SteinbeckG., and FranzW.M. (2009). Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell. Stem Cell., 4, 313–323.
119.
ZhangH., Bosch-MarceM., ShimodaL.A., TanY.S., BaekJ.H., WesleyJ.B., GonzalezF.J., and SemenzaG.L. (2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J. Biol. Chem., 283, 10892–10903.
120.
ZhouS., ChenH.Z., WanY.Z., ZhangQ.J., WeiY.S., HuangS., LiuJ.J., LuY.B., ZhangZ.Q., YangR.F., ZhangR., CaiH., LiuD.P., and LiangC.C. (2011). Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ. Res., 109, 639–648.
121.
ZhuY., MassenS., TerenzioM., LangV., Chen-LindnerS., EilsR., NovakI., DikicI., Hamacher-BradyA., and BradyN.R. (2013). Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J. Biol. Chem., 288, 1099–1113.
